Panacos Pharmaceuticals, Inc. (PANC)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 4, 2025

Panacos Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2007FY 2006FY 2005FY 2004FY 20032001 - 2002
Period Ending
Dec '25 Dec '07 Dec '06 Dec '05 Dec '04 Dec '03 2001 - 2002
042203341--
Upgrade
Market Cap Growth
-98.99%-79.21%-40.36%---
Upgrade
Enterprise Value
-3137328--
Upgrade
Last Close Price
0.000.794.016.93--
Upgrade
PS Ratio
0.00234.97716.22325.13--
Upgrade
PB Ratio
0.001.473.473.98--
Upgrade
P/TBV Ratio
0.001.473.473.98--
Upgrade
EV/Sales Ratio
-16.46483.91313.15--
Upgrade
Debt / Equity Ratio
3.450.670.010.000.05-1.05
Upgrade
Asset Turnover
0.000.000.000.020.350.59
Upgrade
Quick Ratio
2.117.099.3415.041.880.15
Upgrade
Current Ratio
2.157.239.6715.231.900.17
Upgrade
Return on Equity (ROE)
-168.83%-85.57%-52.83%-132.65%-6973.70%-
Upgrade
Return on Assets (ROA)
-52.62%-38.88%-28.86%-31.15%-158.47%-148.30%
Upgrade
Return on Capital Employed (ROCE)
-202.30%-78.10%-61.40%-28.40%-266.60%149.30%
Upgrade
Earnings Yield
-66212962.96%-88.57%-18.74%-17.32%--
Upgrade
FCF Yield
-57857407.41%-73.49%-14.82%-6.39%--
Upgrade
Buyback Yield / Dilution
-2.05%-5.19%-46.77%-3478.27%-138.71%17.62%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.